Processa Pharmaceuticals, Inc. - PCSA

SEC Filings Our PCSA Tweets

About Gravity Analytica

Recent News

  • 07.29.2026 - PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
  • 07.29.2026 - PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
  • 01.12.2026 - Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
  • 01.12.2026 - Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
  • 01.05.2026 - Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
  • 01.05.2026 - Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
  • 12.17.2025 - Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
  • 12.17.2025 - Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
  • 11.05.2025 - Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
  • 11.05.2025 - Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025

Recent Filings

  • 07.30.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.30.2026 - 3 Initial statement of beneficial ownership of securities
  • 07.29.2026 - 8-K Current report
  • 07.29.2026 - EX-99.1 EX-99.1
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.28.2026 - 4 Statement of changes in beneficial ownership of securities